(PRWEB) July 31, 2013
The Global Oncology Biomarker Market is expected to grow from $4.1 billion in 2009 to $9.5 billion in 2014 at a CAGR of 18.1% from 2009 to 2014. The Global Oncology Biomarkers Market report analyzes the oncology biomarkers diagnostics and discovery market over the period 2009-2014. The report studies the major market drivers, restraints, and opportunities for the oncology biomarkers market.
Early buyers will receive 10% customization on this report.
The global oncology biomarker market is expected to grow from $4.1 billion in 2009 to $9.5 billion in 2014 at a CAGR of 18.1% from 2009 to 2014. The key factors driving the growth of the overall oncology biomarkers market include the rising prevalence of cancer across the globe; and the early diagnosis and enhanced testing capabilities biomarkers facilitate. Further, U.S. government initiatives and increasing patient awareness are also enhancing market growth.
Market players are now focusing on new product and consolidations to enhance their commercial portfolios. The most common strategies adopted by market players include agreement and collaborations to stabilize management costs and to take advantage of the core competencies of the partner company.
SCOPE AND FORMAT
The report analyzes the Oncology biomarkers market into the following segments:
Oncology biomarkers discovery market
Oncology biomarkers diagnostics market
The market data consists of aggregate sales figures of all oncology biomarkers submarkets. It analyzes the market aspects of products and services; sourcing key market developments from the top companies that it profiles.
Buy a copy of this report @: http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=202
Download Free Brochure @: http://www.marketsandmarkets.com/pdfdownload.asp?id=202
Find related Reports to – Pharmaceuticals Market
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Connect with us on LinkedIn
Connect with us on Facebook
Read the full story at http://www.prweb.com/releases/oncology-biomarkers/market/prweb10983252.htm.
Copyright©2012 Vocus, Inc.
All rights reserved